View and Apply for a Grant
The Alzheimer's Association works to identify and fund a wide range of the most promising grant projects, from basic discovery science to studies addressing social and behavioral aspects of Alzheimer's and related dementias.
The Alzheimer's Association International Research Grant Program offers a number of funding opportunities throughout the year. Please see the funding program guidelines for more information. Specific details about particular programs can be found below.
- 2026 Part the Cloud Enable the Molecule for Therapeutics Funding Program (PTC-EMT)
- 2026 Part the Cloud Translational Gene Targeting Challenge (PTC-TGTC)
- 2026 Part the Cloud Translational Research for Alzheimer’s Disease Program (PTC-TRAD)
- Alzheimer's Association Funding Program for Global Real-World Data Programs (ALZ-RWD)
- Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)
- Alzheimer’s Disease Strategic Fund: Vascular Contributions to Cognitive Impairment and Dementia - Understanding Mechanisms of Dysfunction (VCID-UMD)
- ISTAART Grant Program for Conferences and Convenings (IGPCC)
- Pilot Awards for Global Brain Health Leaders (Invitation Only)
Active Alzheimer's Association Grants
The following funding programs are accepting letters of intent (LOI) or applications at this time. View the grants' eligibility and deadlines. You can also select a grant for more information. The majority of our grants are open to U.S. and international researchers.
| Grant Name | Eligibility Guidelines | Important Dates |
|---|---|---|
| 2026 Part the Cloud Enable the Molecule for Therapeutics Funding Program (PTC-EMT) |
This program is specifically designed to support therapeutic development for Alzheimer’s disease and related dementias (ADRD) at the IND-enabling stage of drug development. This critical phase bridges advanced preclinical work with entry into first-in-human clinical trials. Applications will be accepted from organizations conducting studies around the world. Researchers with full-time staff or faculty appointments are encouraged to apply. Applications from post- doctoral candidates will not be accepted. |
Letter of Intent deadline: August 6, 2025, 5 p.m. ET Application deadline: September 24, 2025, 5 p.m. ET Award notifications: November 15, 2025 |
| 2026 Part the Cloud Translational Gene Targeting Challenge (PTC-Gene) |
Applications will be accepted from academic investigators and small companies with lead candidate therapeutic agents that require early stage testing prior (Phase 1) to Proof of Concept (POC) Phase 2 or 3 efficacy studies, or with lead therapeutic agents that have already established human safety data and require a small-scale pilot Proof of Mechanism (POM) study in humans to begin proving the scientific concept in humans. |
Letter of Intent deadline: August 6, 2025, 5 p.m. ET Application deadline: September 24, 2025, 5 p.m. ET Award notifications: November 15, 2025 |
| 2026 Part the Cloud Translational Research for Alzheimer’s Disease Program: Phase 1 and Phase 2 Clinical Studies (PTC) |
Applications will be accepted from academic investigators and small companies with lead candidate therapeutic agents that require early stage testing prior (Phase 1) to Proof of Concept (POC) Phase 2 or 3 efficacy studies, or with lead therapeutic agents that have already established human safety data and require a small-scale pilot Proof of Mechanism (POM) study in humans to begin proving the scientific concept in humans. |
Letter of Intent deadline: August 6, 2025, 5 p.m. ET Application deadline: September 24, 2025, 5 p.m. ET Award notifications: November 15, 2025 |
| Alzheimer's Association Funding Program for Global Real-Word Data Programs (ALZ-RWD) |
Proposals must:
|
Pre-submission inquiries are accepted at any time. |
| Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP) |
Applicants must be a member of the World Wide FINGERS Network. |
Pre-submission inquiries are accepted at any time. |
| ISTAART Grant Program for Conferences and Convenings (IGPCC) | The IGPCC Grant Program is open to ISTAART PIA Executive Committee Members to submit on behalf of the PIA. View more details |
Application deadlines: April 9, 2025, 5 p.m. ET (Cycle C) Application reviews: April - June 2025 (Cycle C) Award notifications: By mid-June 2025 (Cycle C) |
| Alzheimer’s Disease Strategic Fund: Vascular Contributions to Cognitive Impairment and Dementia - Understanding Mechanisms of Dysfunction (VCID-UMD) |
The VCID-UMD Grant Program is open to researchers at academic institutions and other non-profit research institutions. The Principal Investigator of the project must be a full-time faculty member (Assistant Professor, Instructor, Lecturer or higher) or full time paid employee of the organization submitting the proposal. Applications from post-doctoral researchers will not be accepted, however, they can be included on applications as key personnel. |
Letter of Intent deadline: May 30, 2025 Application deadline: August 12, 2025 Award notifications: By October 1, 2025 |
Partnership Funding Programs
Partnership Funding Programs are jointly funded by the Alzheimer's Association and other foundations and organizations. View the grants' eligibility guidelines and important dates. You can also select a grant for more information. The majority of our grants are open to U.S. and international researchers.
| Grant Name | Eligibility Guidelines | Important Dates |
|---|---|---|
| Pilot Awards for Global Brain Health Leaders (Invitation Only) | Targeting Atlantic Fellows at GBHI, including alumni, who have not previously received a Pilot Awards for Global Brain Health Leaders award. View more details |
Letter of Intent deadline: March 5, 2025, 11:59 p.m. ET Phase 1 Submission deadline: May 2, 2025, 11:59 p.m. ET Phase 2 Submission deadline: July 9, 2025, 11:59 p.m. ET Award notifications: By October 8, 2025 |
Past grant programs
Looking for funding opportunities previously offered through the Alzheimer’s Association International Research Grant Program?